Yüklüyor......
Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma
BACKGROUND: Although sorafenib is considered standard therapy for advanced hepatocellular carcinoma (HCC), actual treatments vary. We evaluated the effects of different treatment strategies on overall survival. METHODS: A retrospective study of sorafenib-treated patients with advanced HCC was conduc...
Kaydedildi:
| Yayımlandı: | Oncotarget |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Impact Journals LLC
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5342054/ https://ncbi.nlm.nih.gov/pubmed/27494871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11030 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|